TNFRSF11A and breast neoplasm: The essential role of the RANKL/RANK signaling pathway in the early stages of tumorigenesis was shown in a recent study describing the response of a RANK-positive luminal progenitor (LP) subset (present in BRCA1 mutation carriers) to progesterone-induced RANKL as responsible for the transformation of LPs into basal-like breast tumor cells.